Engineered Cas9 variants bypass Keap1-mediated degradation in human cells and enhance epigenome editing efficiency.
Chen J, Su S, Pickar-Oliver A, Chiarella AM, Hahn Q, Goldfarb D, Cloer EW, Small GW, Sivashankar S, Ramsden DA, Major MB, Hathaway NA, Gersbach CA, Liu P.
Chen J, et al. Among authors: hathaway na.
Nucleic Acids Res. 2024 Oct 28;52(19):11536-11551. doi: 10.1093/nar/gkae761.
Nucleic Acids Res. 2024.
PMID: 39228373
Free PMC article.